Home
>
National Drug Code (NDC)
>
PREZISTA
PREZISTA - 59676-564-01 - (darunavir)
Drug Information of PREZISTA
| Product NDC: | 59676-564 |
| Proprietary Name: | PREZISTA |
| Non Proprietary Name: | darunavir |
| Active Ingredient(s): | 150 mg/1 & nbsp; darunavir |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of PREZISTA
| Product NDC: | 59676-564 |
| Labeler Name: | Janssen Products LP |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021976 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20090427 |
Package Information of PREZISTA
| Package NDC: | 59676-564-01 |
| Package Description: | 240 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (59676-564-01) |
NDC Information of PREZISTA
| NDC Code | 59676-564-01 |
| Proprietary Name | PREZISTA |
| Package Description | 240 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (59676-564-01) |
| Product NDC | 59676-564 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | darunavir |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20090427 |
| Marketing Category Name | NDA |
| Labeler Name | Janssen Products LP |
| Substance Name | DARUNAVIR ETHANOLATE |
| Strength Number | 150 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC] |
